APGE Q1 2025 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$63M

Net Income

-$55M

EPS (Diluted)

$-0.95

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$53M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$714M

Total Liabilities

$41M

Stockholders' Equity

$673M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$63M	-$38M	-65.3%
Net Income	-$55M	-$32M	-72.4%